Skip to main content

Prolymphocytic Progression of Chronic Lymphocytic Leukemia in the Era of Novel Targeted Therapies: A Nationwide Veterans Affairs Retrospective Review

Publication ,  Conference
Lin, C; Scobie, M; Friedman, D; Kelley, M; Rodgers, T
Published in: Blood
November 15, 2022

Duke Scholars

Published In

Blood

DOI

ISSN

0006-4971

Publication Date

November 15, 2022

Volume

140

Issue

Supplemental 1

Start / End Page

4176 / 4177

Location

New Orleans, LA

Publisher

American Society of Hematology

Conference Name

American Society of Hematology Annual Meeting

Related Subject Headings

  • Immunology
  • 3213 Paediatrics
  • 3201 Cardiovascular medicine and haematology
  • 3101 Biochemistry and cell biology
  • 1114 Paediatrics and Reproductive Medicine
  • 1103 Clinical Sciences
  • 1102 Cardiorespiratory Medicine and Haematology
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Lin, C., Scobie, M., Friedman, D., Kelley, M., & Rodgers, T. (2022). Prolymphocytic Progression of Chronic Lymphocytic Leukemia in the Era of Novel Targeted Therapies: A Nationwide Veterans Affairs Retrospective Review. In Blood (Vol. 140, pp. 4176–4177). New Orleans, LA: American Society of Hematology. https://doi.org/10.1182/blood-2022-157414
Lin, Chenyu, Micaela Scobie, Daphne Friedman, Michael Kelley, and Thomas Rodgers. “Prolymphocytic Progression of Chronic Lymphocytic Leukemia in the Era of Novel Targeted Therapies: A Nationwide Veterans Affairs Retrospective Review.” In Blood, 140:4176–77. American Society of Hematology, 2022. https://doi.org/10.1182/blood-2022-157414.
Lin C, Scobie M, Friedman D, Kelley M, Rodgers T. Prolymphocytic Progression of Chronic Lymphocytic Leukemia in the Era of Novel Targeted Therapies: A Nationwide Veterans Affairs Retrospective Review. In: Blood. American Society of Hematology; 2022. p. 4176–7.
Lin, Chenyu, et al. “Prolymphocytic Progression of Chronic Lymphocytic Leukemia in the Era of Novel Targeted Therapies: A Nationwide Veterans Affairs Retrospective Review.” Blood, vol. 140, no. Supplemental 1, American Society of Hematology, 2022, pp. 4176–77. Manual, doi:10.1182/blood-2022-157414.
Lin C, Scobie M, Friedman D, Kelley M, Rodgers T. Prolymphocytic Progression of Chronic Lymphocytic Leukemia in the Era of Novel Targeted Therapies: A Nationwide Veterans Affairs Retrospective Review. Blood. American Society of Hematology; 2022. p. 4176–4177.

Published In

Blood

DOI

ISSN

0006-4971

Publication Date

November 15, 2022

Volume

140

Issue

Supplemental 1

Start / End Page

4176 / 4177

Location

New Orleans, LA

Publisher

American Society of Hematology

Conference Name

American Society of Hematology Annual Meeting

Related Subject Headings

  • Immunology
  • 3213 Paediatrics
  • 3201 Cardiovascular medicine and haematology
  • 3101 Biochemistry and cell biology
  • 1114 Paediatrics and Reproductive Medicine
  • 1103 Clinical Sciences
  • 1102 Cardiorespiratory Medicine and Haematology